Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
49,607
+24,136
+95% +$516K 0.15% 221
2026
Q1
$489K Sell
25,471
-21,158
-45% -$471K 0.09% 449
2025
Q4
$894K Buy
46,629
+5,534
+13% +$116K 0.14% 252
2025
Q3
$990K Buy
41,095
+11,385
+38% +$266K 0.15% 214
2025
Q2
$578K Buy
+29,710
New +$439K 0.1% 402
2024
Q1
Sell
-20,244
Closed -$736K 723
2023
Q4
$736K Buy
+20,244
New +$695K 0.19% 166
2021
Q1
Sell
-6,997
Closed -$243K 197
2020
Q4
$243K Sell
6,997
-3,895
-36% -$110K 0.49% 98
2020
Q3
$189K Buy
+10,892
New +$190K 0.47% 129
2020
Q1
Sell
-9,484
Closed -$202K 110
2019
Q4
$202K Buy
+9,484
New +$210K 0.16% 327
2019
Q3
Sell
-8,890
Closed -$216K 344
2019
Q2
$216K Buy
+8,890
New +$183K 0.14% 344
2019
Q1
Sell
-16,554
Closed -$249K 438
2018
Q4
$249K Buy
+16,554
New +$428K 0.13% 332

Other funds holding ADNT

Fox Run Management's ADNT Position: Q2 2026 in Review

Fox Run Management increased its Adient (ADNT) stake by 95% in Q2 2026, buying an estimated $516K and bringing the position to 49,607 shares worth $912K. The position accounts for 0.15% of the portfolio, ranked #221.

Fox Run Management first reported a position in ADNT in Q4 2018 and has held it in 11 quarters since. The position peaked at $990K in Q3 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Fox Run Management held 49,607 shares of Adient worth $912K as of Q2 2026.
  • Fox Run Management bought 24,136 Adient shares in Q2 2026, an estimated $516K.
  • Adient made up 0.15% of Fox Run Management's portfolio in Q2 2026, its #221 holding.
  • Fox Run Management first reported a position in Adient in Q4 2018 and has held it in 11 quarters since.
  • Fox Run Management's Adient position peaked at $990K in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.